Aggressive Chronic Lymphocytic Leukemia with Elevated Genomic Complexity Is Associated with Multiple Gene Defects in the Response to DNA Double-Strand Breaks
Purpose: Genomic complexity is present in approximately 15% to 30% of all chronic lymphocytic leukemia (CLL) and has emerged as a strong independent predictor of rapid disease progression and short remission duration in CLL. We conducted this study to advance our understanding of the causes of genom...
Saved in:
Published in: | Clinical cancer research Vol. 16; no. 3; pp. 835 - 847 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Philadelphia, PA
American Association for Cancer Research
01-02-2010
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Purpose: Genomic complexity is present in approximately 15% to 30% of all chronic lymphocytic leukemia (CLL) and has emerged as a
strong independent predictor of rapid disease progression and short remission duration in CLL. We conducted this study to
advance our understanding of the causes of genomic complexity in CLL.
Experimental Design: We have obtained quantitative measurements of radiation-induced apoptosis and radiation-induced ATM autophosphorylation in
purified CLL cells from 158 and 140 patients, respectively, and have used multivariate analysis to identify independent contributions
of various biological variables on genomic complexity in CLL.
Results: Here, we identify a strong independent effect of radiation resistance on elevated genomic complexity in CLL and describe
radiation resistance as a predictor for shortened CLL survival. Furthermore, using multivariate analysis, we identify del17p/p53
aberrations, del11q, del13q14 type II (invariably resulting in Rb loss), and CD38 expression as independent predictors of genomic complexity in CLL, with aberrant p53 as a predictor of ∼50%
of genomic complexity in CLL. Focusing on del11q, we determined that normalized ATM activity was a modest predictor of genomic
complexity but was not independent of del11q. Through single nucleotide polymorphism array–based fine mapping of del11q, we
identified frequent monoallelic loss of Mre11 and H2AFX in addition to ATM , indicative of compound del11q–resident gene defects in the DNA double-strand break response.
Conclusions: Our quantitative analysis links multiple molecular defects, including for the first time del11q and large 13q14 deletions
(type II), to elevated genomic complexity in CLL, thereby suggesting mechanisms for the observed clinical aggressiveness of
CLL in patients with unstable genomes. Clin Cancer Res; 16(3); 835–47 |
---|---|
AbstractList | Genomic complexity is present in approximately 15% to 30% of all chronic lymphocytic leukemia (CLL) and has emerged as a strong independent predictor of rapid disease progression and short remission duration in CLL. We conducted this study to advance our understanding of the causes of genomic complexity in CLL.
We have obtained quantitative measurements of radiation-induced apoptosis and radiation-induced ATM autophosphorylation in purified CLL cells from 158 and 140 patients, respectively, and have used multivariate analysis to identify independent contributions of various biological variables on genomic complexity in CLL.
Here, we identify a strong independent effect of radiation resistance on elevated genomic complexity in CLL and describe radiation resistance as a predictor for shortened CLL survival. Furthermore, using multivariate analysis, we identify del17p/p53 aberrations, del11q, del13q14 type II (invariably resulting in Rb loss), and CD38 expression as independent predictors of genomic complexity in CLL, with aberrant p53 as a predictor of approximately 50% of genomic complexity in CLL. Focusing on del11q, we determined that normalized ATM activity was a modest predictor of genomic complexity but was not independent of del11q. Through single nucleotide polymorphism array-based fine mapping of del11q, we identified frequent monoallelic loss of Mre11 and H2AFX in addition to ATM, indicative of compound del11q-resident gene defects in the DNA double-strand break response.
Our quantitative analysis links multiple molecular defects, including for the first time del11q and large 13q14 deletions (type II), to elevated genomic complexity in CLL, thereby suggesting mechanisms for the observed clinical aggressiveness of CLL in patients with unstable genomes. Purpose: Genomic complexity is present in approximately 15% to 30% of all chronic lymphocytic leukemia (CLL) and has emerged as a strong independent predictor of rapid disease progression and short remission duration in CLL. We conducted this study to advance our understanding of the causes of genomic complexity in CLL. Experimental Design: We have obtained quantitative measurements of radiation-induced apoptosis and radiation-induced ATM autophosphorylation in purified CLL cells from 158 and 140 patients, respectively, and have used multivariate analysis to identify independent contributions of various biological variables on genomic complexity in CLL. Results: Here, we identify a strong independent effect of radiation resistance on elevated genomic complexity in CLL and describe radiation resistance as a predictor for shortened CLL survival. Furthermore, using multivariate analysis, we identify del17p/p53 aberrations, del11q, del13q14 type II (invariably resulting in Rb loss), and CD38 expression as independent predictors of genomic complexity in CLL, with aberrant p53 as a predictor of ∼50% of genomic complexity in CLL. Focusing on del11q, we determined that normalized ATM activity was a modest predictor of genomic complexity but was not independent of del11q. Through single nucleotide polymorphism array–based fine mapping of del11q, we identified frequent monoallelic loss of Mre11 and H2AFX in addition to ATM , indicative of compound del11q–resident gene defects in the DNA double-strand break response. Conclusions: Our quantitative analysis links multiple molecular defects, including for the first time del11q and large 13q14 deletions (type II), to elevated genomic complexity in CLL, thereby suggesting mechanisms for the observed clinical aggressiveness of CLL in patients with unstable genomes. Clin Cancer Res; 16(3); 835–47 Purpose: Genomic complexity is present in approximately 15% to 30% of all chronic lymphocytic leukemia (CLL) and has emerged as a strong independent predictor of rapid disease progression and short remission duration in CLL. We conducted this study to advance our understanding of the causes of genomic complexity in CLL. Experimental Design: We have obtained quantitative measurements of radiation-induced apoptosis and radiation-induced ATM autophosphorylation in purified CLL cells from 158 and 140 patients, respectively, and have used multivariate analysis to identify independent contributions of various biological variables on genomic complexity in CLL. Results: Here, we identify a strong independent effect of radiation resistance on elevated genomic complexity in CLL and describe radiation resistance as a predictor for shortened CLL survival. Furthermore, using multivariate analysis, we identify del17p/p53 aberrations, del11q, del13q14 type II (invariably resulting in Rb loss), and CD38 expression as independent predictors of genomic complexity in CLL, with aberrant p53 as a predictor of ∼50% of genomic complexity in CLL. Focusing on del11q, we determined that normalized ATM activity was a modest predictor of genomic complexity but was not independent of del11q. Through single nucleotide polymorphism array–based fine mapping of del11q, we identified frequent monoallelic loss of Mre11 and H2AFX in addition to ATM, indicative of compound del11q–resident gene defects in the DNA double-strand break response. Conclusions: Our quantitative analysis links multiple molecular defects, including for the first time del11q and large 13q14 deletions (type II), to elevated genomic complexity in CLL, thereby suggesting mechanisms for the observed clinical aggressiveness of CLL in patients with unstable genomes. Clin Cancer Res; 16(3); 835–47 |
Author | Peter Ouillette Samuel Fossum Brian Parkin Ammar Al-Zoubi Li Ding Paula Bockenstedt Sami N. Malek Kerby Shedden |
AuthorAffiliation | 1 Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA 2 Department of Statistics, University of Michigan, Ann Arbor, MI, USA |
AuthorAffiliation_xml | – name: 2 Department of Statistics, University of Michigan, Ann Arbor, MI, USA – name: 1 Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA |
Author_xml | – sequence: 1 givenname: Peter surname: OUILLETTE fullname: OUILLETTE, Peter organization: Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan, United States – sequence: 2 givenname: Samuel surname: FOSSUM fullname: FOSSUM, Samuel organization: Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan, United States – sequence: 3 givenname: Brian surname: PARKIN fullname: PARKIN, Brian organization: Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan, United States – sequence: 4 surname: LI DING fullname: LI DING organization: Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan, United States – sequence: 5 givenname: Paula surname: BOCKENSTEDT fullname: BOCKENSTEDT, Paula organization: Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan, United States – sequence: 6 givenname: Ammar surname: AL-ZOUBI fullname: AL-ZOUBI, Ammar organization: Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan, United States – sequence: 7 givenname: Kerby surname: SHEDDEN fullname: SHEDDEN, Kerby organization: Department of Statistics, University of Michigan, Ann Arbor, Michigan, United States – sequence: 8 givenname: Sami N surname: MALEK fullname: MALEK, Sami N organization: Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22447420$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20086003$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkdtu1DAQhi1URA_wCCDfIK5SfIqTvUHaZkuptIBU4NpynMnGNIkj27tlH4Z3xem2Ba480v_NeOzvFB2NbgSEXlNyTmlevqekKDMiODuvqpuMLDKWc_EMndA8LzLOZH6U6kfmGJ2G8JMQKigRL9AxI6SUhPAT9Hu52XgIwe4AV513ozV4vR-mzpl9nGvY3sJgNb6zscOXPex0hAZfweiGFFdumHr4ZeMeXwe8DMEZew_c45-3fbQpn3HAK2jBxIDtiGMH-AbC5MYAODq8-rLEK7ete8i-Ra_HBl940LfhJXre6j7Aq4fzDP34ePm9-pStv15dV8t1ZkTBYtbIumzzQjZUNrzIjWxZKziVgjLZGgY5AUN10xgiU0oYKWpS1jUTQjYLsdD8DH04zJ229QCNgTFt0avJ20H7vXLaqv-T0XZq43aKlbSUkqcB-WGA8S4ED-1TLyVq9qVmF2p2oZIvRRZq9pX63vx78VPXo6AEvH0AdDC6b9PnGBv-cukNhWAkce8OXGc33Z31oEwiwSe3oL3pFJWKq5Ln_A_B07EW |
CODEN | CCREF4 |
CitedBy_id | crossref_primary_10_1002_gcc_21997 crossref_primary_10_1038_jhg_2015_166 crossref_primary_10_1038_onc_2012_411 crossref_primary_10_1111_bjh_15421 crossref_primary_10_1182_blood_2012_09_458265 crossref_primary_10_1007_s12185_019_02788_7 crossref_primary_10_1038_leu_2010_288 crossref_primary_10_1186_s13039_017_0353_1 crossref_primary_10_1371_journal_pone_0066361 crossref_primary_10_3960_jslrt_20036 crossref_primary_10_1146_annurev_pathmechdis_012419_032810 crossref_primary_10_1016_j_exphem_2011_11_005 crossref_primary_10_1016_j_ijscr_2023_108748 crossref_primary_10_1038_nrc_2016_8 crossref_primary_10_1038_leu_2016_134 crossref_primary_10_1182_asheducation_2010_1_70 crossref_primary_10_1200_JCO_2011_41_0852 crossref_primary_10_1182_asheducation_2014_1_119 crossref_primary_10_3109_10428194_2012_702902 crossref_primary_10_1002_ajh_23978 crossref_primary_10_1016_j_pathol_2022_12_354 crossref_primary_10_1042_BCJ20160256 crossref_primary_10_5045_br_2020_2020080 crossref_primary_10_1017_erm_2020_3 crossref_primary_10_1155_2014_435983 crossref_primary_10_3109_10428194_2013_829919 crossref_primary_10_1111_cas_13859 crossref_primary_10_1111_bjh_13254 crossref_primary_10_1002_humu_22057 crossref_primary_10_1111_j_1365_2141_2011_09022_x crossref_primary_10_1182_bloodadvances_2020003726 crossref_primary_10_1182_blood_2010_12_327858 crossref_primary_10_1080_10428194_2018_1498494 crossref_primary_10_1053_j_seminoncol_2016_02_002 crossref_primary_10_1002_ajh_23545 crossref_primary_10_1158_1078_0432_CCR_11_2342 crossref_primary_10_1159_000443820 crossref_primary_10_3389_fgene_2015_00207 crossref_primary_10_1038_leu_2014_297 crossref_primary_10_1038_leu_2016_10 crossref_primary_10_1371_journal_pone_0100950 crossref_primary_10_1038_s41375_020_0714_3 crossref_primary_10_1016_j_anndiagpath_2010_08_003 crossref_primary_10_1084_jem_20131448 crossref_primary_10_1158_1078_0432_CCR_11_0785 crossref_primary_10_1182_bloodadvances_2017015560 crossref_primary_10_1155_2014_106713 crossref_primary_10_1158_1078_0432_CCR_10_2058 |
Cites_doi | 10.1200/JCO.2006.06.9492 10.1038/nature02820 10.1080/09553000110120364 10.1038/sj.leu.2404935 10.1038/sj.leu.2404120 10.1016/j.cell.2004.11.022 10.1038/sj.onc.1210880 10.1182/blood-2004-07-2713 10.1182/blood-2008-04-154070 10.1182/blood.V98.9.2633 10.1182/blood-2001-11-0066 10.1038/ng1861 10.1182/blood-2002-06-1683 10.1038/leu.2008.274 10.1182/blood-2006-05-020735 10.1182/blood.V94.6.1848 10.1182/blood-2003-09-3236 10.1182/blood-2004-07-2888 10.1016/S0092-8674(03)00566-X 10.1182/blood.V100.4.1410.h81602001410_1410_1416 10.1158/0008-5472.CAN-07-3105 10.1182/blood-2002-10-3306 10.1111/j.1600-0609.2008.01177.x 10.1182/blood.V100.4.1177.h81602001177_1177_1184 10.1182/blood-2008-01-129726 10.1182/blood.V84.9.3148.3148 10.1038/sj.leu.2404764 10.1200/JCO.2008.16.7874 10.1056/NEJMoa040857 10.1126/science.2565047 10.1159/000167821 10.1182/blood-2007-07-099432 10.1200/JCO.2007.11.2649 10.1016/j.cell.2008.08.015 10.1182/blood-2005-05-2093 10.1038/sj.onc.1207318 10.1016/S0140-6736(03)15260-9 10.1016/j.cell.2007.06.016 10.1038/nature01368 10.1073/pnas.0803520105 10.1056/NEJM200012283432602 10.1182/blood.V98.3.814 10.1182/blood-2004-11-4516 10.1182/blood-2007-09-112698 10.1182/blood.V94.6.1840 10.1182/blood.V98.1.181 10.1200/JCO.2006.08.3089 10.1056/NEJMoa023143 10.1182/blood-2006-02-005322 |
ContentType | Journal Article |
Copyright | 2015 INIST-CNRS |
Copyright_xml | – notice: 2015 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
DOI | 10.1158/1078-0432.CCR-09-2534 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1557-3265 |
EndPage | 847 |
ExternalDocumentID | 10_1158_1078_0432_CCR_09_2534 20086003 22447420 16_3_835 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: 1 R21 CA124420-01A1 – fundername: NCI NIH HHS grantid: R21 CA124420-02 – fundername: NCI NIH HHS grantid: 1R01 CA136537-01 – fundername: NCI NIH HHS grantid: 5 P30 CA46592 – fundername: NCI NIH HHS grantid: R01 CA136537-01A1 – fundername: NCI NIH HHS grantid: P30 CA046592 – fundername: NCI NIH HHS grantid: R01 CA136537 – fundername: NCI NIH HHS grantid: R21 CA124420-01A1 – fundername: NCI NIH HHS grantid: R21 CA124420 |
GroupedDBID | - 29B 2WC 34G 39C 3O- 4H- 53G 5GY 5RE 5VS AAPBV ABFLS ABOCM ACIWK ACPRK ADACO ADBBV AENEX AFFNX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL C1A CS3 DIK DU5 E3Z EBS EJD F5P FH7 FRP GX1 H13 IH2 KQ8 L7B LSO O0- OK1 P0W P2P RCR RHF RHI RNS SJN UDS W2D WOQ ZA5 --- .55 .GJ 08R 18M 1CY 2FS 476 6J9 AAUGY ACGFO ACSVP ADCOW ADNWM AETEA AFHIN AFOSN AI. BR6 BTFSW H~9 IQODW J5H MVM OHT QTD TR2 VH1 W8F WHG X7M XFK XJT YKV ZCG ZGI CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
ID | FETCH-LOGICAL-c472t-d6b8f576d16d375c6f2f43164126fc2e50ec1addc0675c0207b08bb2446d949a3 |
ISSN | 1078-0432 |
IngestDate | Tue Sep 17 21:28:21 EDT 2024 Thu Nov 21 21:03:01 EST 2024 Sat Sep 28 07:59:43 EDT 2024 Sun Oct 29 17:09:04 EDT 2023 Fri Jan 15 19:22:25 EST 2021 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Double stranded DNA Chronic lymphocytic leukemia Lymphoproliferative syndrome Genomics Genetics Malignant hemopathy Mutation Genome Cancer Complexity High malignancy |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c472t-d6b8f576d16d375c6f2f43164126fc2e50ec1addc0675c0207b08bb2446d949a3 |
OpenAccessLink | https://aacrjournals.org/clincancerres/article-pdf/16/3/835/1994158/835.pdf |
PMID | 20086003 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2818663 crossref_primary_10_1158_1078_0432_CCR_09_2534 pubmed_primary_20086003 pascalfrancis_primary_22447420 highwire_cancerresearch_16_3_835 |
ProviderPackageCode | RHF RHI |
PublicationCentury | 2000 |
PublicationDate | 2010-02-01 |
PublicationDateYYYYMMDD | 2010-02-01 |
PublicationDate_xml | – month: 02 year: 2010 text: 2010-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Philadelphia, PA |
PublicationPlace_xml | – name: Philadelphia, PA – name: United States |
PublicationTitle | Clinical cancer research |
PublicationTitleAlternate | Clin Cancer Res |
PublicationYear | 2010 |
Publisher | American Association for Cancer Research |
Publisher_xml | – name: American Association for Cancer Research |
References | 18281475 - Cancer Res. 2008 Feb 15;68(4):1012-21 12149224 - Blood. 2002 Aug 15;100(4):1404-9 12149225 - Blood. 2002 Aug 15;100(4):1410-6 15329427 - N Engl J Med. 2004 Aug 26;351(9):893-901 15138159 - Blood. 2004 Sep 1;104(5):1428-34 11675331 - Blood. 2001 Nov 1;98(9):2633-9 18854157 - Cell. 2008 Oct 3;135(1):85-96 17003373 - Blood. 2007 Jan 15;109(2):399-404 18436738 - Blood. 2008 Sep 1;112(5):1993-2003 11136261 - N Engl J Med. 2000 Dec 28;343(26):1910-6 7949187 - Blood. 1994 Nov 1;84(9):3148-57 18689542 - Blood. 2008 Oct 15;112(8):3322-9 10477712 - Blood. 1999 Sep 15;94(6):1840-7 16840733 - Blood. 2006 Nov 1;108(9):3152-60 18843282 - Leukemia. 2009 Jan;23(1):117-24 10477713 - Blood. 1999 Sep 15;94(6):1848-54 12194750 - Int J Radiat Biol. 2002 Aug;78(8):671-9 18066087 - Oncogene. 2007 Dec 10;26(56):7749-58 12595313 - Blood. 2003 Jun 15;101(12):4944-51 11468183 - Blood. 2001 Aug 1;98(3):814-22 15550242 - Cell. 2004 Nov 24;119(5):591-602 16014569 - Blood. 2005 Nov 1;106(9):3175-82 18424664 - Blood. 2008 Jun 15;111(12):5646-53 14755251 - Oncogene. 2004 Mar 11;23(10):1911-21 9788599 - Cancer Res. 1998 Oct 15;58(20):4552-7 18599436 - Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9302-6 16921376 - Nat Genet. 2006 Sep;38(9):1043-8 12724482 - N Engl J Med. 2003 May 1;348(18):1764-75 2565047 - Science. 1989 Apr 14;244(4901):207-11 16437137 - Leukemia. 2006 Apr;20(4):737-40 12914700 - Cell. 2003 Aug 8;114(3):359-70 12556884 - Nature. 2003 Jan 30;421(6922):499-506 17971485 - Blood. 2008 Feb 1;111(3):1584-93 18467710 - J Clin Oncol. 2008 May 10;26(14):e5-6 16179374 - Blood. 2006 Jan 15;107(2):742-51 19018867 - Eur J Haematol. 2009 Feb;82(2):133-42 17283363 - J Clin Oncol. 2007 Mar 1;25(7):799-804 15692065 - Blood. 2005 Jun 1;105(11):4484-91 19188704 - Cytogenet Genome Res. 2008;122(3-4):343-9 15306814 - Nature. 2004 Aug 12;430(7001):797-802 17805327 - Leukemia. 2007 Dec;21(12):2442-51 15718417 - Blood. 2005 Jun 15;105(12):4776-83 17968022 - J Clin Oncol. 2007 Dec 1;25(34):5448-57 17008705 - J Clin Oncol. 2006 Oct 1;24(28):4634-41 12393534 - Blood. 2002 Dec 15;100(13):4609-14 17541398 - Leukemia. 2007 Aug;21(8):1715-22 11418478 - Blood. 2001 Jul 1;98(1):181-6 17599403 - Cell. 2007 Jul 13;130(1):63-75 14726163 - Lancet. 2004 Jan 10;363(9403):105-11 12149195 - Blood. 2002 Aug 15;100(4):1177-84 Krober (2022061023012781600_bib26) 2002; 100 Jones (2022061023012781600_bib43) 2004; 23 Orchard (2022061023012781600_bib30) 2004; 363 Bassing (2022061023012781600_bib47) 2003; 114 Starostik (2022061023012781600_bib15) 1998; 58 Aydin (2022061023012781600_bib50) 2008; 111 Oscier (2022061023012781600_bib28) 2002; 100 Rassenti (2022061023012781600_bib22) 2004; 351 Callen (2022061023012781600_bib46) 2007; 130 Wattel (2022061023012781600_bib40) 1994; 84 Buis (2022061023012781600_bib44) 2008; 135 Deriano (2022061023012781600_bib39) 2005 Del Poeta (2022061023012781600_bib23) 2001; 98 Hernando (2022061023012781600_bib49) 2004; 430 Zenz (2022061023012781600_bib13) 2008; 112 Austen (2022061023012781600_bib10) 2007; 25 Carter (2022061023012781600_bib48) 2006; 20 Bond (2022061023012781600_bib33) 2004; 119 Lin (2022061023012781600_bib27) 2002; 100 Dicker (2022061023012781600_bib9) 2006; 108 Austen (2022061023012781600_bib11) 2005; 106 Byrd (2022061023012781600_bib17) 2007; 109 Pettitt (2022061023012781600_bib36) 2001; 98 Mayr (2022061023012781600_bib4) 2006; 107 Shanafelt (2022061023012781600_bib2) 2006; 24 Grever (2022061023012781600_bib3) 2007; 25 Wiestner (2022061023012781600_bib21) 2003; 101 Van Den Neste (2022061023012781600_bib7) 2007; 21 Cejkova (2022061023012781600_bib42) 2009; 82 Chen (2022061023012781600_bib25) 2002; 100 Vogelstein (2022061023012781600_bib34) 1989; 244 Damle (2022061023012781600_bib20) 1999; 94 Ouillette (2022061023012781600_bib32) 2008; 68 Lavin (2022061023012781600_bib31) 2007; 26 Salin (2022061023012781600_bib38) 2008; 122 Alvi (2022061023012781600_bib18) 2005; 105 Saddler (2022061023012781600_bib12) 2008; 111 Bakkenist (2022061023012781600_bib41) 2003; 421 Hamblin (2022061023012781600_bib19) 1999; 94 Zha (2022061023012781600_bib45) 2008; 105 Rosenwald (2022061023012781600_bib16) 2004; 104 Dicker (2022061023012781600_bib14) 2009; 23 Crespo (2022061023012781600_bib29) 2003; 348 Blaise (2022061023012781600_bib37) 2002; 78 Kujawski (2022061023012781600_bib6) 2008; 112 Haferlach (2022061023012781600_bib8) 2007; 21 Dohner (2022061023012781600_bib1) 2000; 343 Carter (2022061023012781600_bib35) 2006; 38 Ibrahim (2022061023012781600_bib24) 2001; 98 Shanafelt (2022061023012781600_bib5) 2008; 26 |
References_xml | – volume: 24 start-page: 4634 year: 2006 ident: 2022061023012781600_bib2 article-title: Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia publication-title: J Clin Oncol doi: 10.1200/JCO.2006.06.9492 contributor: fullname: Shanafelt – volume: 430 start-page: 797 year: 2004 ident: 2022061023012781600_bib49 article-title: Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control publication-title: Nature doi: 10.1038/nature02820 contributor: fullname: Hernando – volume: 58 start-page: 4552 year: 1998 ident: 2022061023012781600_bib15 article-title: Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia publication-title: Cancer Res contributor: fullname: Starostik – volume: 78 start-page: 671 year: 2002 ident: 2022061023012781600_bib37 article-title: High levels of chromosome aberrations correlate with impaired in vitro radiation-induced apoptosis and DNA repair in human B-chronic lymphocytic leukaemia cells publication-title: Int J Radiat Biol doi: 10.1080/09553000110120364 contributor: fullname: Blaise – volume: 21 start-page: 2442 year: 2007 ident: 2022061023012781600_bib8 article-title: Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping publication-title: Leukemia doi: 10.1038/sj.leu.2404935 contributor: fullname: Haferlach – volume: 20 start-page: 737 year: 2006 ident: 2022061023012781600_bib48 article-title: Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia publication-title: Leukemia doi: 10.1038/sj.leu.2404120 contributor: fullname: Carter – volume: 119 start-page: 591 year: 2004 ident: 2022061023012781600_bib33 article-title: A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans publication-title: Cell doi: 10.1016/j.cell.2004.11.022 contributor: fullname: Bond – volume: 26 start-page: 7749 year: 2007 ident: 2022061023012781600_bib31 article-title: ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks publication-title: Oncogene doi: 10.1038/sj.onc.1210880 contributor: fullname: Lavin – volume: 105 start-page: 4484 year: 2005 ident: 2022061023012781600_bib18 article-title: A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival publication-title: Blood doi: 10.1182/blood-2004-07-2713 contributor: fullname: Alvi – volume: 112 start-page: 3322 year: 2008 ident: 2022061023012781600_bib13 article-title: Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up publication-title: Blood doi: 10.1182/blood-2008-04-154070 contributor: fullname: Zenz – volume: 98 start-page: 2633 year: 2001 ident: 2022061023012781600_bib23 article-title: Clinical significance of CD38 expression in chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood.V98.9.2633 contributor: fullname: Del Poeta – volume: 100 start-page: 1404 year: 2002 ident: 2022061023012781600_bib27 article-title: Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood-2001-11-0066 contributor: fullname: Lin – volume: 38 start-page: 1043 year: 2006 ident: 2022061023012781600_bib35 article-title: A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers [see comment] publication-title: Nat Genet doi: 10.1038/ng1861 contributor: fullname: Carter – volume: 100 start-page: 4609 year: 2002 ident: 2022061023012781600_bib25 article-title: Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood-2002-06-1683 contributor: fullname: Chen – volume: 23 start-page: 117 year: 2009 ident: 2022061023012781600_bib14 article-title: The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype publication-title: Leukemia doi: 10.1038/leu.2008.274 contributor: fullname: Dicker – volume: 109 start-page: 399 year: 2007 ident: 2022061023012781600_bib17 article-title: Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood-2006-05-020735 contributor: fullname: Byrd – volume: 94 start-page: 1848 year: 1999 ident: 2022061023012781600_bib19 article-title: Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood.V94.6.1848 contributor: fullname: Hamblin – volume: 104 start-page: 1428 year: 2004 ident: 2022061023012781600_bib16 article-title: Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response publication-title: Blood doi: 10.1182/blood-2003-09-3236 contributor: fullname: Rosenwald – year: 2005 ident: 2022061023012781600_bib39 article-title: Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the non-homologous end-joining DNA repair pathway publication-title: Blood doi: 10.1182/blood-2004-07-2888 contributor: fullname: Deriano – volume: 114 start-page: 359 year: 2003 ident: 2022061023012781600_bib47 article-title: Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors publication-title: Cell doi: 10.1016/S0092-8674(03)00566-X contributor: fullname: Bassing – volume: 100 start-page: 1410 year: 2002 ident: 2022061023012781600_bib26 article-title: V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood.V100.4.1410.h81602001410_1410_1416 contributor: fullname: Krober – volume: 68 start-page: 1012 year: 2008 ident: 2022061023012781600_bib32 article-title: Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-3105 contributor: fullname: Ouillette – volume: 101 start-page: 4944 year: 2003 ident: 2022061023012781600_bib21 article-title: ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile publication-title: Blood doi: 10.1182/blood-2002-10-3306 contributor: fullname: Wiestner – volume: 82 start-page: 133 year: 2009 ident: 2022061023012781600_bib42 article-title: Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine publication-title: Eur J Haematol doi: 10.1111/j.1600-0609.2008.01177.x contributor: fullname: Cejkova – volume: 100 start-page: 1177 year: 2002 ident: 2022061023012781600_bib28 article-title: Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors publication-title: Blood doi: 10.1182/blood.V100.4.1177.h81602001177_1177_1184 contributor: fullname: Oscier – volume: 111 start-page: 5646 year: 2008 ident: 2022061023012781600_bib50 article-title: CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome? publication-title: Blood doi: 10.1182/blood-2008-01-129726 contributor: fullname: Aydin – volume: 84 start-page: 3148 year: 1994 ident: 2022061023012781600_bib40 article-title: p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies publication-title: Blood doi: 10.1182/blood.V84.9.3148.3148 contributor: fullname: Wattel – volume: 21 start-page: 1715 year: 2007 ident: 2022061023012781600_bib7 article-title: Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine publication-title: Leukemia doi: 10.1038/sj.leu.2404764 contributor: fullname: Van Den Neste – volume: 26 start-page: e5 year: 2008 ident: 2022061023012781600_bib5 article-title: Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression publication-title: J Clin Oncol doi: 10.1200/JCO.2008.16.7874 contributor: fullname: Shanafelt – volume: 351 start-page: 893 year: 2004 ident: 2022061023012781600_bib22 article-title: ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia publication-title: N Engl J Med doi: 10.1056/NEJMoa040857 contributor: fullname: Rassenti – volume: 244 start-page: 207 year: 1989 ident: 2022061023012781600_bib34 article-title: Allelotype of colorectal carcinomas publication-title: Science (New York, NY) doi: 10.1126/science.2565047 contributor: fullname: Vogelstein – volume: 122 start-page: 343 year: 2008 ident: 2022061023012781600_bib38 article-title: Increased genomic alteration complexity and telomere shortening in B-CLL cells resistant to radiation-induced apoptosis publication-title: Cytogenet Genome Res doi: 10.1159/000167821 contributor: fullname: Salin – volume: 112 start-page: 1993 year: 2008 ident: 2022061023012781600_bib6 article-title: Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood-2007-07-099432 contributor: fullname: Kujawski – volume: 25 start-page: 5448 year: 2007 ident: 2022061023012781600_bib10 article-title: Mutation Status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion publication-title: J Clin Oncol doi: 10.1200/JCO.2007.11.2649 contributor: fullname: Austen – volume: 135 start-page: 85 year: 2008 ident: 2022061023012781600_bib44 article-title: Mre11 nuclease activity has essential roles in DNA repair and genomic stability distinct from ATM activation publication-title: Cell doi: 10.1016/j.cell.2008.08.015 contributor: fullname: Buis – volume: 107 start-page: 742 year: 2006 ident: 2022061023012781600_bib4 article-title: Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood-2005-05-2093 contributor: fullname: Mayr – volume: 23 start-page: 1911 year: 2004 ident: 2022061023012781600_bib43 article-title: The ATR-p53 pathway is suppressed in noncycling normal and malignant lymphocytes publication-title: Oncogene doi: 10.1038/sj.onc.1207318 contributor: fullname: Jones – volume: 363 start-page: 105 year: 2004 ident: 2022061023012781600_bib30 article-title: ZAP-70 expression and prognosis in chronic lymphocytic leukaemia publication-title: Lancet doi: 10.1016/S0140-6736(03)15260-9 contributor: fullname: Orchard – volume: 130 start-page: 63 year: 2007 ident: 2022061023012781600_bib46 article-title: ATM prevents the persistence and propagation of chromosome breaks in lymphocytes publication-title: Cell doi: 10.1016/j.cell.2007.06.016 contributor: fullname: Callen – volume: 421 start-page: 499 year: 2003 ident: 2022061023012781600_bib41 article-title: DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation publication-title: Nature doi: 10.1038/nature01368 contributor: fullname: Bakkenist – volume: 105 start-page: 9302 year: 2008 ident: 2022061023012781600_bib45 article-title: Complementary functions of ATM and H2AX in development and suppression of genomic instability publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0803520105 contributor: fullname: Zha – volume: 343 start-page: 1910 year: 2000 ident: 2022061023012781600_bib1 article-title: Genomic aberrations and survival in chronic lymphocytic leukemia publication-title: N Engl J Med doi: 10.1056/NEJM200012283432602 contributor: fullname: Dohner – volume: 98 start-page: 814 year: 2001 ident: 2022061023012781600_bib36 article-title: p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation publication-title: Blood doi: 10.1182/blood.V98.3.814 contributor: fullname: Pettitt – volume: 106 start-page: 3175 year: 2005 ident: 2022061023012781600_bib11 article-title: Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL publication-title: Blood doi: 10.1182/blood-2004-11-4516 contributor: fullname: Austen – volume: 111 start-page: 1584 year: 2008 ident: 2022061023012781600_bib12 article-title: Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood-2007-09-112698 contributor: fullname: Saddler – volume: 94 start-page: 1840 year: 1999 ident: 2022061023012781600_bib20 article-title: Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood.V94.6.1840 contributor: fullname: Damle – volume: 98 start-page: 181 year: 2001 ident: 2022061023012781600_bib24 article-title: CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood.V98.1.181 contributor: fullname: Ibrahim – volume: 25 start-page: 799 year: 2007 ident: 2022061023012781600_bib3 article-title: Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997 publication-title: J Clin Oncol doi: 10.1200/JCO.2006.08.3089 contributor: fullname: Grever – volume: 348 start-page: 1764 year: 2003 ident: 2022061023012781600_bib29 article-title: ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia publication-title: N Engl J Med doi: 10.1056/NEJMoa023143 contributor: fullname: Crespo – volume: 108 start-page: 3152 year: 2006 ident: 2022061023012781600_bib9 article-title: Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression publication-title: Blood doi: 10.1182/blood-2006-02-005322 contributor: fullname: Dicker |
SSID | ssj0014104 |
Score | 2.2902656 |
Snippet | Purpose: Genomic complexity is present in approximately 15% to 30% of all chronic lymphocytic leukemia (CLL) and has emerged as a
strong independent predictor... Genomic complexity is present in approximately 15% to 30% of all chronic lymphocytic leukemia (CLL) and has emerged as a strong independent predictor of rapid... Purpose: Genomic complexity is present in approximately 15% to 30% of all chronic lymphocytic leukemia (CLL) and has emerged as a strong independent predictor... |
SourceID | pubmedcentral crossref pubmed pascalfrancis highwire |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 835 |
SubjectTerms | Antineoplastic agents Apoptosis - radiation effects Ataxia Telangiectasia Mutated Proteins Biological and medical sciences Cell Cycle Proteins - metabolism Chromosome Deletion Chromosomes, Human, Pair 11 Chromosomes, Human, Pair 13 CLL DNA Breaks, Double-Stranded DNA double-strand break response DNA-Binding Proteins - metabolism genomic complexity Hematologic and hematopoietic diseases Humans Leukemia, Lymphocytic, Chronic, B-Cell - genetics Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Medical sciences Mutation Pharmacology. Drug treatments Phosphorylation Protein-Serine-Threonine Kinases - metabolism Radiation Tolerance Tumor Suppressor Proteins - metabolism |
Title | Aggressive Chronic Lymphocytic Leukemia with Elevated Genomic Complexity Is Associated with Multiple Gene Defects in the Response to DNA Double-Strand Breaks |
URI | http://clincancerres.aacrjournals.org/content/16/3/835.abstract https://www.ncbi.nlm.nih.gov/pubmed/20086003 https://pubmed.ncbi.nlm.nih.gov/PMC2818663 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb5tAEF45qVT1UvUd9xHtoTfklOeCjw5e2zQ2WAZHyQnxVHOIGzn2z-l_7Qy7vNQe2kq9IAQDi_b7dnZmmZ0h5HPBtMyyE3NU5HkCDopmjpIkA1fFNliRa2Wh5_hHdxHa_o0z5SYfDOrKjO21_4o0XAOscefsX6DdvBQuwDlgDkdAHY5_hPtkPsdO9a654i42gQ-9vLxdrReBexvhOd9eQdeDOvCihcKX_HoCukuZ86qcoeIGq_WS33jRreKFIuejVwlU4qvtMvLgPopzZcpn3I1wC3IVNwStrgM_5EoUKFN_MpoG20sQxaLM_lS53PDJVdg1hd16T2aGxNsrMu1QszwdHHGb4kGU7-uFEc9gYhflmcPk_lg0MSK4g1uWn993WD-VZVuWd90lDvw734SLCK2sYhpg0-irbdahp9HRwY7If_Lr3GA51TKFfNeF624w8EO3xGpqhxsP9xU5MDQE7EGjnSrr8ID1ytWrVIHGCXmig4pDDRt-9Zv_V6ZWFa5sGpN7x-ATvvz2AzAntWytbyDVSasxZjd5BFBKUW-lYzD1g3k71lH0gjyXbg2dCD6-JINi94o8XcnAjdfkR0tLKmlJO7SkNS0p8ozWtKSSlrSlJfVC2tJSiNe0RHFOJS2p51OgJa1pSaOAtrSkgpZU0PIN2c545C5GsjLIKDNt_TDKWeqU4CnnGssN28pYqZeY08HUdFZmemGpRabBzJ2hP5yBR2SnqpOmYMqyfGyOE-MtOd193xVnhKq5WrJEzVmWgfPO9BQLFKS5Y5VjozAMNiQXNRzxg0gAE1eOs-XECGWMUMYAZayOY4RySGgNWiwGUD1-Yo3FRgz0HJLzHpjNi8GeNm1TV4fknQC1vSPZMSR2D-5GANPE9-_s7r5V6eIlU9__85MfyLN2VH4kp4f9sfhETh7z43nF-p90EcWX |
link.rule.ids | 230,315,782,786,887,27933,27934 |
linkProvider | Multiple Vendors |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=AGGRESSIVE+CHRONIC+LYMPHOCYTIC+LEUKEMIA+WITH+ELEVATED+GENOMIC+COMPLEXITY+IS+ASSOCIATED+WITH+MULTIPLE+GENE+DEFECTS+IN+THE+RESPONSE+TO+DNA-DOUBLE+STRAND+BREAKS&rft.jtitle=Clinical+cancer+research&rft.au=Ouillette%2C+Peter&rft.au=Fossum%2C+Samuel&rft.au=Parkin%2C+Brian&rft.au=Ding%2C+Li&rft.date=2010-02-01&rft.issn=1078-0432&rft.volume=16&rft.issue=3&rft.spage=835&rft_id=info:doi/10.1158%2F1078-0432.CCR-09-2534&rft_id=info%3Apmid%2F20086003&rft.externalDBID=PMC2818663 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-0432&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-0432&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-0432&client=summon |